Your browser doesn't support javascript.
loading
KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms.
Suzuki, Shinichiro; Yonesaka, Kimio; Teramura, Takeshi; Takehara, Toshiyuki; Kato, Ryoji; Sakai, Hitomi; Haratani, Koji; Tanizaki, Junko; Kawakami, Hisato; Hayashi, Hidetoshi; Sakai, Kazuko; Nishio, Kazuto; Nakagawa, Kazuhiko.
Afiliação
  • Suzuki S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Yonesaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan. yonesaka@med.kindai.ac.jp.
  • Teramura T; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Takehara T; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Kato R; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Sakai H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Haratani K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Tanizaki J; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Sakai K; Department of Genome Biology, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nishio K; Department of Genome Biology, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
Clin Cancer Res ; 27(20): 5697-5707, 2021 10 15.
Article em En | MEDLINE | ID: mdl-34365406
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Pirimidinas / Transdução de Sinais / Amplificação de Genes / Proteínas Proto-Oncogênicas p21(ras) / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-met / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Pirimidinas / Transdução de Sinais / Amplificação de Genes / Proteínas Proto-Oncogênicas p21(ras) / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-met / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article